ST. Vincent's Medical Center, INC.
ST. Vincent's Medical Center, INC. was paid $760K by Medicaid between Jan 2018 and Nov 2024, across 96 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 18% of everything it billed.
JACKSONVILLE, FL 32216
Next to other Clinical Medical Laboratory providers in Florida
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,746 | $3K | |
| 2019 | 34,832 | $150K | |
| 2020 | 32,905 | $199K | |
| 2021 | 32,060 | $220K | |
| 2022 | 26,262 | $184K | |
| 2023 | 984 | $4K | |
| 2024incomplete | 170 | $577.17 |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 18% | 2,680 | 2,138 | $136K |
| 80061 | Lipid panel | 15% | 10,631 | 9,576 | $110K |
| 80050 | General health panel | 10% | 3,346 | 3,147 | $78K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 5.6% | 2,944 | 2,752 | $42K |
| 88142 | 5.0% | 1,297 | 1,257 | $38K | |
| 80074 | 4.3% | 679 | 647 | $33K | |
| 80053 | Comprehensive metabolic panel | 4.0% | 11,548 | 9,520 | $30K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.7% | 4,597 | 4,122 | $28K |
| 83540 | 3.6% | 1,865 | 1,672 | $27K | |
| 87340 | 2.5% | 948 | 909 | $19K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.4% | 1,188 | 1,002 | $18K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.3% | 455 | 413 | $17K |
84 more codes
| 84443 | Thyroid stimulating hormone (TSH) | 2.1% | 6,117 | $16K |
| 82607 | 1.8% | 4,254 | $14K | |
| 86703 | 1.8% | 2,441 | $14K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.5% | 3,906 | $11K |
| 83735 | 1.2% | 1,036 | $9K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.2% | 131 | $9K |
| 84550 | 1.2% | 637 | $9K | |
| 82728 | 1.2% | 2,177 | $9K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.1% | 3,020 | $8K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 924 | $7K |
| 82950 | <1% | 360 | $6K | |
| 82570 | <1% | 2,703 | $6K | |
| 80055 | <1% | 36 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,509 | $6K |
| 36415 | Collection of venous blood by venipuncture | <1% | 17,731 | $5K |
| 87186 | <1% | 1,522 | $5K | |
| 84439 | <1% | 3,674 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 8,458 | $4K |
| 84466 | <1% | 1,676 | $3K | |
| 82043 | <1% | 2,022 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,228 | $3K |
| 86803 | <1% | 1,697 | $2K | |
| 84153 | <1% | 531 | $2K | |
| 82105 | <1% | 255 | $2K | |
| 87081 | <1% | 171 | $2K | |
| 84702 | <1% | 326 | $2K | |
| 86140 | <1% | 1,332 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,596 | $1K |
| 86038 | <1% | 380 | $1K | |
| 80076 | <1% | 375 | $866.95 | |
| 84436 | <1% | 215 | $776.09 | |
| 82746 | <1% | 2,714 | $772.68 | |
| 86592 | <1% | 2,017 | $770.42 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 35 | $769.83 |
| 81001 | <1% | 2,604 | $752.15 | |
| 84156 | <1% | 394 | $668.17 | |
| 84403 | <1% | 82 | $630.00 | |
| 83970 | <1% | 133 | $588.35 | |
| 83655 | <1% | 92 | $498.31 | |
| 85027 | <1% | 1,887 | $393.15 | |
| 81003 | <1% | 1,466 | $358.77 | |
| 80069 | <1% | 277 | $311.16 | |
| 83002 | <1% | 26 | $283.49 | |
| 87480 | <1% | 49 | $282.32 | |
| 84146 | <1% | 49 | $281.00 | |
| 82550 | <1% | 46 | $279.18 | |
| 82140 | <1% | 33 | $278.08 | |
| 86317 | <1% | 86 | $210.14 | |
| 83520 | <1% | 32 | $163.53 | |
| 83001 | <1% | 55 | $163.05 | |
| 85610 | <1% | 735 | $148.24 | |
| 87077 | <1% | 1,067 | $104.75 | |
| 85652 | <1% | 1,229 | $99.52 | |
| 80164 | <1% | 77 | $93.50 | |
| 86694 | <1% | 45 | $83.94 | |
| 86901 | <1% | 186 | $55.37 | |
| 87070 | <1% | 31 | $46.88 | |
| 86900 | <1% | 186 | $44.26 | |
| 86160 | <1% | 17 | $40.92 | |
| 86431 | <1% | 145 | $32.17 | |
| 85730 | <1% | 45 | $31.22 | |
| 86850 | <1% | 204 | $12.10 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 23 | $11.08 |
| 86704 | <1% | 12 | $9.31 | |
| 3044F | <1% | 199 | $9.01 | |
| 82248 | <1% | 56 | $7.36 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 157 | $6.68 |
| 83516 | <1% | 39 | $6.00 | |
| 87660 | <1% | 49 | $5.22 | |
| 87510 | <1% | 49 | $5.22 | |
| 82677 | <1% | 75 | $4.57 | |
| 85660 | <1% | 136 | $4.41 | |
| 86336 | <1% | 75 | $3.31 | |
| 87799 | 0% | 36 | $0.00 | |
| 84425 | 0% | 16 | $0.00 | |
| 80159 | 0% | 59 | $0.00 | |
| 84207 | 0% | 13 | $0.00 | |
| 3051F | 0% | 42 | $0.00 | |
| 87481 | 0% | 46 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 12 | $0.00 |
| 87512 | 0% | 12 | $0.00 | |
| 83615 | 0% | 41 | $0.00 | |
| 84479 | 0% | 137 | $0.00 | |
| 83880 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.